首页> 外国专利> METHOD FOR THE PRODUCTION OF RECOMBINANT ANTIGENS FOR USE AS VACCINES AGAINST CYSTICERCOSIS-TAENIASIS.

METHOD FOR THE PRODUCTION OF RECOMBINANT ANTIGENS FOR USE AS VACCINES AGAINST CYSTICERCOSIS-TAENIASIS.

机译:生产用于抗囊尾S虫病疫苗的重组抗原的方法。

摘要

The present invention consists in using the recombinant protein expression system in embryogenic cells of papaya for the expression and production of protective recombinant proteins against cysticercosis and taeniasis. Three genetic constructions were performed, wherein the sequences encoding for peptides KETc1, KETc7 and KETc12 from the cysticercus T. crassiceps were independently donated to the expression vector pUl235-5.1. Said constructions were used for transforming, by biobalistics, embryogenic papaya (Carica papaya) callus. The embryogenic callus were co-transformed with each one of the genetic construction in the vector pUl235-5.1 and the vector pWRG1515 which contain the GUS reporter gene that encodes for the (-glucuronidase) enzyme (Christou et al., 1995). The transformed callus were selected and isolated in a selective medium with antibiotics. The ability of expression and immunogenicity of the produced clones were confirmed. Based on the immunogenic ability of the clones, the clones 6p (KETC12.6 His), 9p (KETc1. 6 His) and 23p (KETc7) were selected therefrom, the same being spread, preserved and started the regeneration process in vitro.
机译:本发明在于使用重组蛋白表达系统在木瓜的胚发生细胞中表达和生产针对囊尾rc虫病和虫病的保护性重组蛋白。进行了三种遗传构建,其中将来自于啤酒囊球菌的编码肽KETc1,KETc7和KETc12的序列独立地捐赠给表达载体pUl235-5.1。所述构建体用于通过生物统计学方法转化胚性木瓜(Carica papaya)愈伤组织。将胚性愈伤组织与载体pUl235-5.1和载体pWRG1515中的每个基因构建体共转化,所述载体包含编码(-葡萄糖醛酸苷酶)酶的GUS报告基因(Christou等,1995)。选择转化的愈伤组织,并在具有抗生素的选择性培养基中分离。证实了所产生的克隆的表达能力和免疫原性。根据克隆的免疫原性,从中选择克隆6p(KETC12.6His),9p(KETc1.6His)和23p(KETc7),将其传播,保存并在体外开始再生过程。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号